Log in | Register

Therapeutic targets in necrotizing soft tissue infections

Nicolas de Prost| Jeffrey Lipman| Olivier Mimoz
Editorial
Volume 43, Issue 11 / November , 2017

Pages 1717 - 1719

No abstract available.

References

  1. Das DK, Baker MG, Venugopal K (2012) Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review. BMC Infect Dis 12:348
    • View reference on publisher's website
    • View reference on PubMed
  2. Hua C, Sbidian E, Hemery F, Decousser JW, Bosc R, Amathieu R, Rahmouni A, Wolkenstein P, Valeyrie-Allanore L, Brun-Buisson C, de Prost N, Chosidow O (2015) Prognostic factors in necrotizing soft-tissue infections (NSTI): a cohort study. J Am Acad Dermatol 73(1006–1012):e1008
  3. Swartz MN (2004) Clinical practice. Cellulitis. N Engl J Med 350:904–912
    • View reference on publisher's website
    • View reference on PubMed
  4. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377
  5. Perner A, Gordon AC, De Backer D, Dimopoulos G, Russell JA, Lipman J, Jensen JU, Myburgh J, Singer M, Bellomo R, Walsh T (2016) Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med 42:1958–1969
  6. Pham TN, Moore ML, Costa BA, Cuschieri J, Klein MB (2009) Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res 30:301–306
    • View reference on publisher's website
    • View reference on PubMed
  7. Elliott DC, Kufera JA, Myers RA (1996) Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224:672–683
    • View reference on publisher's website
    • View reference on PubMed
  8. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59:e10–52
    • View reference on publisher's website
    • View reference on PubMed
  9. Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358–365
    • View reference on publisher's website
    • View reference on PubMed
  10. de Prost N, Sbidian E, Chosidow O, Brun-Buisson C, Amathieu R, Henri Mondor Hospital Necrotizing Fasciitis Group (2015) Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med 41:1506–1508
  11. Kadri SS, Swihart BJ, Bonne SL, Hohmann SF, Hennessy LV, Louras P, Evans HL, Rhee C, Suffredini AF, Hooper DC, Follmann DA, Bulger EM, Danner RL (2017) Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity score-matched analysis from 130 US hospitals. Clin Infect Dis 64:877–885
    • View reference on PubMed
  12. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O’Rourke K, Talbot J, Low DE (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28:800–807
    • View reference on publisher's website
    • View reference on PubMed
  13. Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851–857
    • View reference on publisher's website
    • View reference on PubMed
  14. Shah SS, Hall M, Srivastava R, Subramony A, Levin JE (2009) Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 49:1369–1376
    • View reference on publisher's website
    • View reference on PubMed
  15. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, Streptig Study Group (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37:333–340
    • View reference on publisher's website
    • View reference on PubMed
  16. Madsen M, Hjortrup P, Hansen M, Lange T, Norrby-Teglund A, Hyldegaard O, Perner A (2017) Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med. doi:10.1007/s00134-017-4786-0

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement